Hepatorenal syndrome;Le point sur le syndrome hépatorénal

Nephrologie

Volumn 23, Issue 1, 2002, Pages 11-17

  Blaise, P ^a   Moonen, Martial ^a   Rorive, G ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Acute renal failure; Hepatorenal syndrome

Indexed keywords

VASOPRESSIN DERIVATIVE;

DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEPATORENAL SYNDROME; HUMAN; KIDNEY FAILURE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; PATHOGENESIS; PATHOPHYSIOLOGY; PORTOSYSTEMIC ANASTOMOSIS; REVIEW; TREATMENT OUTCOME;

CREATININE; DIAGNOSIS, DIFFERENTIAL; EDEMA; GLOMERULAR FILTRATION RATE; HEPATORENAL SYNDROME; HUMANS; KIDNEY FAILURE, ACUTE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PERITONEOVENOUS SHUNT; PORTASYSTEMIC SHUNT, SURGICAL; RENAL CIRCULATION; RENAL REPLACEMENT THERAPY; RENIN-ANGIOTENSIN SYSTEM; SERUM ALBUMIN; SPLANCHNIC CIRCULATION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; VASOPRESSINS; WATER-ELECTROLYTE IMBALANCE;

EID: 0036183559     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Renal failure in liver disease
2. A liver kidney syndrome: Clinical, pathological and experimental studies
3. Le syndrome hépathorénal
4. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in a important clinical problem
5. Periphral arterial vasodilatation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
6. Update on peripheral arterial vasodilatation, ascites and hepatorenal syndrome in cirrhosis
7. Pathogenesis of water and sodium retention in cirrhosis
8. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis
9. The kidney in liver disease
10. Hyponatremia
11. Renal failure in acute liver failure
12. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome
13. Reduction in renal blood flow following acute increase in the portal pressure: Evidence for the existence of a hepatorenal reflex in man?
14. Acute effects of transjugular intrahepatic portosystemic stent-shunt (TIPSS) procedure on renal blood flow and cardiopulmonary hemodynamics in cirrhosis
15. Acute renal failure in liver disease
16. Reduction of renal cortical blood flow assessed by Doppler in cirrhotic patients with refractory ascites
17. Hepatorenal syndrome: Definition, pathophysiology, clinical features and management
18. Renal vasoconstriction in cirrhosis evaluated by Duplex Doppler ultrasonography
19. Pathogenesis of ascites formation: Mechanisms of impaired aldosterone escape in cirrhosis
20. Transplantation of cadaveric kidneys from patients with hepato-renal syndrome
21. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
22. La cirrhose
23. Hepatorenal syndrome without avid sodium retention
24. Pathophysiology of renal dysfunction in cirrhosis
25. New treatments for hepatorenal syndrome
26. Pre-transplant renal dysfonction predicts poorer outcome in liver transplantation
27. Transplantation for alcoholic liver disease: A perspective from Europe
28. Hepatorenal syndrome
29. Bioartificial liver support system using porcine hepatocytes entrapped in a three-dimensional hollow fiber module with collagen gel: An evaluation in the swine acute liver failure model
30. Treatment with terlipressin as a bridge to liver transplantation in a patient with hepatorenal syndrome
31. Improving prognosis in hepatorenal syndrome
32. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion
33. Terlipressin plus albumin infusion: An effective and safe therapy of hepatorenal syndrome
34. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites
35. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide
36. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems
37. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites
38. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: A phase II study
39. Is there a role for continuous renal replacement therapies in patients with liver and renal failure?
40. Renal replacement therapies
41. Cerebral blood flow and metabolism in fulminant hepatic failure
42. Circulatory, respiratory, cerebral and renal derangements in acute liver failure: Pathophysiology and management
43. Anticoagulation in patients with acute renal failure treated with continuous renal remplacement therapies
44. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump driven extracorporeal circuits inpatients with combined acute renal and hepatic failure